BITCHUTE (PragerU) - Peptides: Medical Breakthrough or Risky Shortcut? | Dr. Jared Ament & Dr. Jon Kanevsky 2026-09-23 ..
Peptides, supplements, GLP-1 weight-loss drugs, NAD, IV drips, and “longevity stacks” are everywhere. But how much do people really know about what they are putting into their bodies? Dr. Jared Ament and Dr. Jon Kanevsky join PragerU CEO Marissa Streit to explain the potential benefits of peptides, why so many Americans are experimenting with them, and why the gray-market peptide industry can be risky. They break down FDA approval, third-party testing, China-based sourcing, growth hormone peptides, Ozempic, retatrutide, creatine, NAD, and the role of AI in helping patients research their own health. They also discuss why good medicine requires both curiosity and humility. This episode is part of a series of medical interviews. The…
What topics did Dr. Jared Ament and Dr. Jon Kanevsky cover concerning medical practice and patient research?
They discussed why good medicine requires both curiosity and humility, as well as the role that AI plays in helping patients conduct their own health research.
Q&A ID bf433dd4-cc68-4d3a-8be0-e6982238e787
What are some of the risks mentioned regarding the peptide industry?
The discussion highlights that the gray-market peptide industry can be risky and raises questions about how much people truly know about what they are putting into their bodies.
Q&A ID 2395d233-6540-43d5-9417-43f4b11c7cb3
What specific health-related topics and substances were discussed by Dr. Jared Ament and Dr. Jon Kanevsky?
The discussion covered peptides, supplements, GLP-1 weight-loss drugs, NAD, IV drips, “longevity stacks,” FDA approval, third-party testing, China-based sourcing, growth hormone peptides, Ozempic, retatrutide, creatine, and the role of AI in helping patients research their own health.
Q&A ID c25ab39d-eac1-4921-a497-fd94fcec3029
Who were the featured medical experts in the discussion regarding peptides and longevity stacks on September 23, 2026?
The discussion featured Dr. Jared Ament and Dr. Jon Kanevsky.
Q&A ID 73b4b4b6-08b3-4d77-8e11-9a8531715e47